STRUCTURAL CHARACTERIZATION OF FACTOR-I MEDIATED CLEAVAGE OF THE 3RD COMPONENT OF COMPLEMENT

被引：73
作者：
DAVIS, AE
HARRISON, RA
机构：
[1] CHILDRENS HOSP MED CTR,DIV IMMUNOL,BOSTON,MA 02115
[2] MRC CTR,MECHANISMS TUMOUR IMMUN UNIT,CAMBRIDGE CB2 2QH,ENGLAND
来源：
BIOCHEMISTRY | 1982年 / 21卷 / 23期
关键词：
D O I：
10.1021/bi00266a003
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：5745 / 5749
页数：5
相关论文
共 43 条
[1]  
ABRAMSON N, 1971, J IMMUNOL, V107, P19
[2]   INACTIVATOR OF THIRD COMPONENT OF COMPLEMENT AS AN INHIBITOR IN PROPERDIN PATHWAY [J].
ALPER, CA ;
ROSEN, FS ;
LACHMANN, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1972, 69 (10) :2910-&
[3]   ISOLATION OF A FRAGMENT (C3A) OF THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM [J].
BOKISCH, VA ;
MULLEREB.HJ ;
COCHRANE, CG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (05) :1109-&
[4]   APPLICATION OF 0.1 M-QUADROL TO MICROSEQUENCE OF PROTEINS AND SEQUENCE OF TRYPTIC PEPTIDES [J].
BRAUER, AW ;
MARGOLIES, MN ;
HABER, E .
BIOCHEMISTRY, 1975, 14 (13) :3029-3035
[5]  
BUDZKO DB, 1971, BIOCHEMISTRY-US, V10, P1166
[6]  
COOPER NR, 1975, J EXP MED, V141, P890
[7]   PURIFICATION OF THE HUMAN-COMPLEMENT CONTROL PROTEIN C3B INACTIVATOR [J].
CROSSLEY, LG ;
PORTER, RR .
BIOCHEMICAL JOURNAL, 1980, 191 (01) :173-182
[8]  
DAHA MR, 1976, J IMMUNOL, V117, P630
[9]   COMPLEMENT AS A MEDIATOR OF INFLAMMATION .3. PURIFICATION OF ACTIVITY WITH ANAPHYLATOXIN PROPERTIES GENERATED BY INTERACTION OF FIRST 4 COMPONENTS OF COMPLEMENT AND ITS IDENTIFICATION AS A CLEAVAGE PRODUCT OF C'3 [J].
DASILVA, WD ;
EISELE, JW ;
LEPOW, IH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 126 (06) :1027-&
[10]   THE C3B INACTIVATOR OF THE HUMAN-COMPLEMENT SYSTEM - HOMOLOGY WITH SERINE PROTEASES [J].
DAVIS, AE .
FEBS LETTERS, 1981, 134 (02) :147-150
12345